News

Under the collaboration, Metabolon will apply its platform to discover and validate targets, and identify novel pharmacodynamic biomarkers for translation into the clinic. Metabolon has developed a proprietary

The FDA approved BINOSTO to treat osteoporosis in postmenopausal women and to increase bone mass in men with osteoporosis. Utilizing EffRx’s formulation technology, BINOSTO is the first and

Under the agreement, which is subject to satisfaction of certain closing conditions, CTI will make an upfront payment of $15m and issue $15m shares of unregistered preferred stock

SUGARDOWN, a non-systemic dietary supplement, is a complex carbohydrate-based chewable tablet to moderate post-meal blood glucose for those concerned about their blood glucose levels. Boston will manufacture and

Proteins produced by both treated and control algae were tested with an in vitro activity test assay and found that the treated algae showed hormonal activity. The use

The Moratuwa facility will produce 2.5 billion Panadol brand of paracetamol tablets, annually, according to the Ministry of Industry and Commerce, reports news360.lk. Industry and Commerce minister Rishard

The transaction is expected to close in the second quarter, subject to certain closing conditions including regulatory approvals, and is expected to be immediately accretive. The acquired assets’

Through the investment, Mylan is expected to add more than 500 new positions to its Ireland-based workforce by 2016. The company’s investment will include funding for expanded research

The company now confirms that the $15m milestone associated with its licensing and development agreement with Endo Pharmaceuticals for BEMA Buprenorphine is payable. With this the total milestone